Related content

A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer

By                                          

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 768-772

Spandidos Publications

Access to resources Recommend Favorite

Dosefinding study on adjuvant chemotherapy with S1 plus oxaliplatin for gastric cancer

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 1, 2014-01 ,pp. : 93-98

Spandidos Publications

Access to resources Recommend Favorite

Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs

By                            

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 805-810

Spandidos Publications

Access to resources Recommend Favorite

A Polymorphism (80G->A) in the Reduced Folate Carrier Gene and Its Associations with Folate Status and Homocysteinemia

By Chango A.   Emery-Fillon N.   de Courcy G.P.   Lambert D.   Pfister M.   Rosenblatt D.S.   Nicolas J-P.  

Molecular Genetics and Metabolism, Vol. 70, Iss. 4, 2000-08 ,pp. : 310-315

Academic Press

Access to resources Recommend Favorite

Amifostine, in a reduced dose, protects against severe diarrhea associated with weekly fluorouracil and folinic acid chemotherapy in advanced colorectal cancer: a pilot study

By Tsavaris N.   Kosmas C.   Vadiaka M.   Zonios D.   Papalambros E.   Papantoniou N.   Margaris H.   Zografos G.   Rokana S.   Retalis G.   Koufos C.  

Journal of Pain and Symptom Management, Vol. 26, Iss. 3, 2003-09 ,pp. : 849-854

Elsevier

Access to resources Recommend Favorite